These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Bronchoalveolar lavage in sarcoidosis]. Sato S Nihon Rinsho; 2002 Sep; 60(9):1766-71. PubMed ID: 12233073 [TBL] [Abstract][Full Text] [Related]
9. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from healthy individuals and sarcoidosis patients. Golec M; Reichel C; Lemieszek M; Buczkowski J; Mackiewicz B; Skórska C; Dutkiewicz J; Góra A; Ziesche R; Milanowski J J Biol Regul Homeost Agents; 2014; 28(1):73-9. PubMed ID: 24750793 [TBL] [Abstract][Full Text] [Related]
10. Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Inui N; Murayama A; Sasaki S; Suda T; Chida K; Kato S; Nakamura H Am J Med; 2001 Jun; 110(9):687-93. PubMed ID: 11403752 [TBL] [Abstract][Full Text] [Related]
11. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis. Wikén M; Idali F; Al Hayja MA; Grunewald J; Eklund A; Wahlström J Respir Res; 2010 Sep; 11(1):121. PubMed ID: 20813038 [TBL] [Abstract][Full Text] [Related]
12. Increased interleukin-13 expression in patients with sarcoidosis. Hauber HP; Gholami D; Meyer A; Pforte A Thorax; 2003 Jun; 58(6):519-24. PubMed ID: 12775866 [TBL] [Abstract][Full Text] [Related]
13. Carbon nanotube-induced pulmonary granulomatous disease: Twist1 and alveolar macrophage M1 activation. Barna BP; Huizar I; Malur A; McPeek M; Marshall I; Jacob M; Dobbs L; Kavuru MS; Thomassen MJ Int J Mol Sci; 2013 Dec; 14(12):23858-71. PubMed ID: 24322444 [TBL] [Abstract][Full Text] [Related]
14. Shed soluble ICAM-1 molecules in bronchoalveolar lavage cell supernatants and serum of patients with pulmonary sarcoidosis. Bäumer I; Zissel G; Schlaak M; Müller-Quernheim J Lung; 1997; 175(2):105-16. PubMed ID: 9042667 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D, Cathelicidin, Prolactin, Autoantibodies, and Cytokines in Different Forms of Pulmonary Tuberculosis versus Sarcoidosis. Vasilyevna Belyaeva I; Pavlovitch Churilov L; Robertovnа Mikhailova L; Vladimirovitch Nikolaev A; Andreevna Starshinova A; Kazimirovitch Yablonsky P Isr Med Assoc J; 2017 Aug; 19(8):499-505. PubMed ID: 28825769 [TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis. Zheng L; Teschler H; Guzman J; Hübner K; Striz I; Costabel U Am J Respir Crit Care Med; 1995 Sep; 152(3):1061-6. PubMed ID: 7663784 [TBL] [Abstract][Full Text] [Related]
17. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta. Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912 [TBL] [Abstract][Full Text] [Related]
18. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. Schauber J; Oda Y; Büchau AS; Yun QC; Steinmeyer A; Zügel U; Bikle DD; Gallo RL J Invest Dermatol; 2008 Apr; 128(4):816-24. PubMed ID: 17943182 [TBL] [Abstract][Full Text] [Related]
19. 1,25-dihydroxycholecalciferol stimulates ICAM-1 expression of human alveolar macrophages in healthy controls and patients with sarcoidosis. Braun J; Dinkelacker C; Bohnet S; Kreft B; Dalhoff K Lung; 1999; 177(3):139-49. PubMed ID: 10192761 [TBL] [Abstract][Full Text] [Related]
20. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis. Oltmanns U; Schmidt B; Hoernig S; Witt C; John M Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]